Evidence map›Paper›PMID 29498310›Full record

ReviewInternational journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group2018

An overview of the role of sympathetic regulation of immune responses in infectious disease and autoimmunity.

Mark J Bucsek, Thejaswini Giridharan, Cameron R MacDonald, Bonnie L Hylander, Elizabeth A Repasky

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05638620 (Evaluating the Effectiveness of Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Post-Acute Sequelae of SARS-CoV-2), which is not on this map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05638620 phase1completednot on this mapstarted 2023, after this paper: background citation

Evaluating the Effectiveness of Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Post-Acute Sequelae of SARS-CoV-2 (PASC)

TypeinterventionalSponsorJonathann Kuo, MDRan2023 to 2023Enrolled20ConditionsPost Acute COVID-19 Syndrome, Long COVID, Long Covid19, COVID-19 RecurrentArmsstellate ganglion block with 0.5% bupivacaine
3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 60 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Targeting nerve growth factor: an Achilles' heel for tumors?Journal for immunotherapy of cancer · 2025
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Neuroendocrine contribution to sex-related variations in adverse air pollution health effects.Journal of toxicology and environmental health. Part B, Critical reviews · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mark J Bucseka Department of Immunology , Roswell Park Cancer Institute , Buffalo , NY , USA.
Thejaswini Giridharana Department of Immunology , Roswell Park Cancer Institute , Buffalo , NY , USA.
Cameron R MacDonalda Department of Immunology , Roswell Park Cancer Institute , Buffalo , NY , USA.
Bonnie L Hylandera Department of Immunology , Roswell Park Cancer Institute , Buffalo , NY , USA.
Elizabeth A Repaskya Department of Immunology , Roswell Park Cancer Institute , Buffalo , NY , USA.
Roswell Park Comprehensive Cancer Center · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MARK G FRATTINI · 1985 to 2026
$116.6M
MULTIDISCIPLINARY APPROACHES TUMOR IMMUNOLOGYT32CA085183 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Scott I. Abrams · 2001 to 2026
$3.1M
Activating adrenergic receptors to suppress the anti-graft immune response and improve survival of composite tissue allograftsR21AI136367 · NIAID · ROSWELL PARK CANCER INSTITUTE CORP · PI KIM, MINHYUNG, REPASKY, ELIZABETH A · 2018 to 2019
$472k
NCI NIH HHS P30 CA016056NCI NIH HHS T32 CA085183NIAID NIH HHS R21 AI136367
6 · The paper itself

Abstract

Stress in patients and pre-clinical research animals plays a critical role in disease progression Activation of the sympathetic nervous system (SNS) by stress results in secretion of the catecholamines epinephrine (Epi) and norepinephrine (NE) from the adrenal gland and sympathetic nerve endings. Adrenergic receptors for catecholamines are present on immune cells and their activity is affected by stress and the accompanying changes in levels of these neurotransmitters. In this short review, we discuss how this adrenergic stress impacts two categories of immune responses, infections and autoimmune diseases. Catecholamines signal primarily through the β2-adrenergic receptors present on innate and adaptive immune cells which are critical in responding to infections caused by pathogens. In general, this adrenergic input, particularly chronic stimulation, suppresses lymphocytes and allows infections to progress. On the other hand, insufficient adrenergic control of immune responses allows progression of several autoimmune diseases.

Indexed as

AutoimmunityCommunicable DiseasesHumansSympathetic Nervous Systemautoimmune diseasesinfectionSNSβ-adrenergic receptor

Identifiers

PMID29498310
PMCPMC6309867
OpenAlexW2792241000

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.